Mercy Announces New Leaders to Enhance Services in Neurosciences, Surgery and GI, Women and Children

08 Jan 2024
Executive ChangeAHA
ST. LOUIS, Jan. 8, 2024 /PRNewswire/ -- Mercy is ushering in a new era of patient-focused care with the introduction of three leaders to spearhead specialty service lines – Brian Connor, neurosciences; Michelle Fortune, surgery and gastroenterology (GI); Dawn Martin, women and children. They join Matt Wright, who leads orthopedics and sports medicine, and Dana Haynie, focused on cancer care, as service line presidents.
Mercy's strategic shift to performance divisions – teams focused on specific tasks to provide patients with a seamless, coordinated experience – includes primary care, specialty service lines and operations. These new leaders will improve patient access across Mercy, while developing impactful strategies, identifying areas for investment and improving performance.
Connor, who now leads neurosciences, brings experience from his role as chief operating officer at Health First in Melbourne, Florida. His leadership spans various health systems in Florida, Oklahoma and Texas, with notable experience at the Oklahoma Stroke & Neurological Institute. With a background in respiratory therapy, he prioritizes connecting with frontline health care workers and fostering a culture of teamwork and excellence.
Fortune, the new leader for surgery and GI services, arrives from St. Luke's Hospital in Columbus, North Carolina, where she served as chief executive officer. With experience in leading outpatient surgery centers, perioperative services and anesthesia at Atrium Health in Charlotte, North Carolina, and National Surgical Hospitals in Chicago, Illinois, Fortune is well prepared to guide the surgery and GI teams and collaborate across services.
Martin, assuming responsibility for the women and children service line, was most recently president and CEO of Ascension Sacred Heart in Pensacola, Florida, where she led a 586-bed hospital with an embedded children's hospital and women's care center. With additional experience in Ascension hospitals in Connecticut and Tennessee, she has a strong background in Catholic health care, leading surgery centers, outpatient facilities and establishing steering councils for key service lines.
"Our goal is to provide a consistently positive experience for our patients and consumers across Mercy's many states," said Dr. Jeff Ciaramita, Mercy president of specialty service lines. "With the collaborative efforts of Brian, Dana, Matt, Michelle and Dawn, together with our regional teams, we are well positioned to enhance and rapidly expand our quality care in each community. This strategic approach will provide our patients with increased access to low-cost, high-quality health care services everywhere that Mercy serves."
Mercy is actively interviewing candidates for the final service line president position in cardiovascular care, reinforcing the commitment to comprehensive and integrated health care services.
Mercy, one of the 20 largest U.S. health systems and named the top large system in the U.S. for excellent patient experience by NRC Health, serves millions annually with nationally recognized quality care and one of the nation's largest Accountable Care Organizations. Mercy is a highly integrated, multi-state health care system including more than 50 acute care and specialty (heart, children's, orthopedic and rehab) hospitals, convenient and urgent care locations, imaging centers and pharmacies. Mercy has over 900 physician practice locations and outpatient facilities, more than 4,500 physicians and advanced practitioners and more than 47,000 co-workers serving patients and families across Arkansas, Kansas, Missouri and Oklahoma. Mercy also has clinics, outpatient services and outreach ministries in Arkansas, Louisiana, Mississippi and Texas.
SOURCE Mercy
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.